Cargando…
Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use
INTRODUCTION: Broadly neutralising antibodies are promising candidates for preventing and treating Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), as an alternative to or in combination with antiretroviral therapy (ART). These mAbs bind to sites on the virus essential for...
Autores principales: | Grandits, Melanie, Grünwald-Gruber, Clemens, Gastine, Silke, Standing, Joseph F., Reljic, Rajko, Teh, Audrey Y-H., Ma, Julian K-C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009187/ https://www.ncbi.nlm.nih.gov/pubmed/36923134 http://dx.doi.org/10.3389/fpls.2023.1126470 |
Ejemplares similares
-
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants
por: Moore, Catherine M., et al.
Publicado: (2021) -
Engineering the N-glycosylation pathway of Nicotiana tabacum for molecular pharming using CRISPR/Cas9
por: Göritzer, Kathrin, et al.
Publicado: (2022) -
Engineering the interactions between a plant‐produced HIV antibody and human Fc receptors
por: Stelter, Szymon, et al.
Publicado: (2019) -
Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants
por: Teh, Audrey Y-H, et al.
Publicado: (2021) -
The Instability of Dimeric Fc-Fusions Expressed in Plants Can Be Solved by Monomeric Fc Technology
por: Gattinger, Pia, et al.
Publicado: (2021)